Are we ready to treat hepatitis c virus ...
Type de document :
Article dans une revue scientifique: Article de synthèse/Review paper
PMID :
URL permanente :
Titre :
Are we ready to treat hepatitis c virus in individuals with opioid use disorder: assessment of readiness in european countries on the basis of an expert-generated model
Auteur(s) :
Wright, Nat [Auteur]
Reimer, Jens [Auteur]
Somaini, Lorenzo [Auteur]
Roncero, Carlos [Auteur]
Maremmani, Icro [Auteur]
Simon, Nicolas [Auteur]
Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA]
Krajci, Peter [Auteur]
Littlewood, Richard [Auteur]
D'agnone, Oscar [Auteur]
Alho, Hannu [Auteur]
Rolland, Benjamin [Auteur]
Reimer, Jens [Auteur]
Somaini, Lorenzo [Auteur]
Roncero, Carlos [Auteur]
Maremmani, Icro [Auteur]
Simon, Nicolas [Auteur]
Groupe de Recherche sur les formes Injectables et les Technologies Associées - ULR 7365 [GRITA]
Krajci, Peter [Auteur]
Littlewood, Richard [Auteur]
D'agnone, Oscar [Auteur]
Alho, Hannu [Auteur]
Rolland, Benjamin [Auteur]
Titre de la revue :
European journal of gastroenterology & hepatology
Nom court de la revue :
Eur. J. Gastroenterol. Hepatol.
Numéro :
29
Pagination :
1206-1214
Date de publication :
2017-11-01
ISSN :
0954-691X
Mot(s)-clé(s) en anglais :
drug injecting
opioid dependence
outcomes
hepatitis C virus treatment
opioid dependence
outcomes
hepatitis C virus treatment
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Individuals with a history of injecting drugs have a high prevalence of chronic hepatitis C (HCV) infection. Many have a history of opioid use disorder (OUD). Despite novel treatments with improved efficacy and tolerability, ...
Lire la suite >Individuals with a history of injecting drugs have a high prevalence of chronic hepatitis C (HCV) infection. Many have a history of opioid use disorder (OUD). Despite novel treatments with improved efficacy and tolerability, treatment is limited in the group. A faculty of experts shared insights from clinical practice to develop an HCV care-readiness model. Evidence and expert knowledge was collected. Ten experts developed a model of three factors (with measures): 'healthcare engagement', 'guidance' and 'place'. Overall, 40-90% of individuals with OUD engage with drug treatment services. Ten of 12 HCV guidelines provided specific advice for the OUD population. Ten of 12 OUD care guidelines provided useful HCV care advice. In 11 of 12 cases, location of HCV/drug treatment care was in different places. This readiness assessment shows that there are important limitations to successful HCV care in OUD. Specific actions should be taken: maintain/increase access to OUD treatment services/opioid agonist therapy, updating HCV guidance, locate care in the same place and allow wider prescribing of anti HCV medicines.Lire moins >
Lire la suite >Individuals with a history of injecting drugs have a high prevalence of chronic hepatitis C (HCV) infection. Many have a history of opioid use disorder (OUD). Despite novel treatments with improved efficacy and tolerability, treatment is limited in the group. A faculty of experts shared insights from clinical practice to develop an HCV care-readiness model. Evidence and expert knowledge was collected. Ten experts developed a model of three factors (with measures): 'healthcare engagement', 'guidance' and 'place'. Overall, 40-90% of individuals with OUD engage with drug treatment services. Ten of 12 HCV guidelines provided specific advice for the OUD population. Ten of 12 OUD care guidelines provided useful HCV care advice. In 11 of 12 cases, location of HCV/drug treatment care was in different places. This readiness assessment shows that there are important limitations to successful HCV care in OUD. Specific actions should be taken: maintain/increase access to OUD treatment services/opioid agonist therapy, updating HCV guidance, locate care in the same place and allow wider prescribing of anti HCV medicines.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Collections :
Date de dépôt :
2019-11-27T13:36:48Z